Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE.

Clin Cancer Res. 2007 Apr 15;13(8):2422-8.

2.

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.

Tarhini AA, Lin Y, Zahoor H, Shuai Y, Butterfield LH, Ringquist S, Gogas H, Sander C, Lee S, Agarwala SS, Kirwood JM.

PLoS One. 2015 Jul 20;10(7):e0132745. doi: 10.1371/journal.pone.0132745. eCollection 2015.

3.

Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.

Shetty G, Beasley GM, Sparks S, Barfield M, Masoud M, Mosca PJ, Pruitt SK, Salama AK, Chan C, Tyler DS, Weinhold KJ.

Ann Surg Oncol. 2013 Apr;20(4):1128-35. doi: 10.1245/s10434-012-2785-5. Epub 2013 Mar 2.

4.

Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma.

Dréau D, Foster M, Hogg M, Swiggett J, Holder WD, White RL.

Oncol Res. 2000;12(5):241-51.

PMID:
11417749
5.

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment.

Ascierto PA, Napolitano M, Celentano E, Simeone E, Gentilcore G, Daponte A, Capone M, Caracò C, Calemma R, Beneduce G, Cerrone M, De Rosa V, Palmieri G, Castello G, Kirkwood JM, Marincola FM, Mozzillo N.

J Transl Med. 2010 Aug 16;8:76. doi: 10.1186/1479-5876-8-76.

6.

An update on pegylated IFN-α2b for the adjuvant treatment of melanoma.

Agarwala SS.

Expert Rev Anticancer Ther. 2012 Nov;12(11):1449-59. doi: 10.1586/era.12.120. Review.

PMID:
23249109
7.

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.

Tarhini AA, Lin Y, Yeku O, LaFramboise WA, Ashraf M, Sander C, Lee S, Kirkwood JM.

J Transl Med. 2014 Jan 23;12:19. doi: 10.1186/1479-5876-12-19.

8.

Serum biomarkers in head and neck squamous cell cancer.

Kaskas NM, Moore-Medlin T, McClure GB, Ekshyyan O, Vanchiere JA, Nathan CA.

JAMA Otolaryngol Head Neck Surg. 2014 Jan;140(1):5-11. doi: 10.1001/jamaoto.2013.5688.

PMID:
24232368
9.

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A.

J Clin Oncol. 2011 Apr 1;29(10):1356-63. doi: 10.1200/JCO.2010.32.9490. Epub 2011 Feb 7.

10.

Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.

Grimm EA, Smid CM, Lee JJ, Tseng CH, Eton O, Buzaid AC.

Clin Cancer Res. 2000 Oct;6(10):3895-903.

11.

Multiplex bead array assay of plasma cytokines in type 2 diabetes mellitus with diabetic retinopathy.

Hang H, Yuan S, Yang Q, Yuan D, Liu Q.

Mol Vis. 2014 Aug 4;20:1137-45. eCollection 2014.

12.

[Association between cytokines and trichloroethylene-induced hypersensitivity dermatitis].

Zang D, Yi J, Dong HY, Zhou W, Huang XQ, Duan HW, Bin P, Niu Y, Zheng YX, Dai YF.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Sep;46(9):836-9. Chinese.

PMID:
23157890
13.

Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.

Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr.

Reprod Biol Endocrinol. 2011 Sep 9;9:124. doi: 10.1186/1477-7827-9-124.

14.

Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.

Crucitti A, Corbi M, Tomaiuolo PM, Fanali C, Mazzari A, Lucchetti D, Migaldi M, Sgambato A.

Cancer Biol Ther. 2015;16(5):671-7. doi: 10.1080/15384047.2015.1026476.

15.

Multiplex determination of murine seminal fluid cytokine profiles.

Gopichandran N, Ekbote UV, Walker JJ, Brooke D, Orsi NM.

Reproduction. 2006 Mar;131(3):613-21.

16.

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhönen S, Syrjänen K, Lundin J, Hernberg M.

Cancer Immunol Immunother. 2015 Feb;64(2):173-80. doi: 10.1007/s00262-014-1620-1. Epub 2014 Oct 16.

PMID:
25319807
17.

Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).

Busse A, Rapion J, Fusi A, Suciu S, Nonnenmacher A, Santinami M, Kruit WH, Testori A, Punt CJ, Dalgleish AG, Spatz A, Eggermont AM, Keilholz U.

Cancer Immunol Immunother. 2013 Jul;62(7):1223-33. doi: 10.1007/s00262-013-1428-4. Epub 2013 Apr 27.

PMID:
23624802
18.

Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.

Carpizo DR, Gensure RH, Yu X, Gendel VM, Greene SJ, Moore DF, Jabbour SK, Nosher JL.

J Vasc Interv Radiol. 2014 Feb;25(2):297-306.e1. doi: 10.1016/j.jvir.2013.10.030. Epub 2013 Dec 20.

PMID:
24360887
19.

Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes.

Xuan ML, Lu CJ, Han L, Xiang Y.

Chin J Integr Med. 2015 Feb;21(2):108-14. doi: 10.1007/s11655-014-1792-0. Epub 2014 Dec 19.

PMID:
25523599
20.

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

Sabatino M, Kim-Schulze S, Panelli MC, Stroncek D, Wang E, Taback B, Kim DW, Deraffele G, Pos Z, Marincola FM, Kaufman HL.

J Clin Oncol. 2009 Jun 1;27(16):2645-52. doi: 10.1200/JCO.2008.19.1106. Epub 2009 Apr 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk